TARPLIN, DOWNS & YOUNG, LLC

Lobbying for BOEHRINGER INGELHEIM · pharmaceutical company focused on innovative therapies for diseases w/o treatment option

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $70,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Budget/Appropriations

federal budget issues

Medicare/Medicaid

Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA

Health Issues

IRA, prescription drug pricing, prescription drug access and affordability, transparency, drug pricing in federal programs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.